Add BrightSurf on Google Email

National Cerebral and Cardiovascular Center


Improved prognosis for chronic thromboembolic pulmonary hypertension over recent decades

Recent studies have revealed significant improvements in patient prognosis for chronic thromboembolic pulmonary hypertension (CTEPH) over the past few decades. Advances in surgical techniques, drug development, and multimodal therapies have led to increased treatment rates and improved survival rates among patients.

SourceNational Cerebral and Cardiovascular Center·JournalEuropean Respiratory Journal·DateJul 14, 2025

Cerebral small vessel disease: predictive for intracranial hemorrhage and probably for extracranial bleeding during antithrombotic therapy

A study found that cerebral small vessel disease is a predictor for major bleeding, including intracranial hemorrhage and extracranial bleeding, in patients taking antithrombotic agents. The risk of bleeding complications increased significantly with higher cerebral SVD scores.

SourceNational Cerebral and Cardiovascular Center·JournalAnnals of Neurology·DateDec 27, 2023

Researchers revealed the benefits and risks of continuing oral anticoagulation therapy after catheter ablation for atrial fibrillation according to the thromboembolic risk

A nationwide cohort study in Japan found that continuing oral anticoagulation therapy after catheter ablation for atrial fibrillation increases the risk of major bleeding but decreases the risk of thromboembolic events. Discontinuing oral anticoagulants in patients with a lower CHADS 2 score may be beneficial.

SourceNational Cerebral and Cardiovascular Center·JournalEuropean Heart Journal·DateDec 19, 2023

Japan's first multicenter investigator-initiated clinical trial of patients with mild cognitive impairment: Results of the COMCID study

The COMCID study demonstrates the safety of cilostazol in patients with MCI, but shows no efficacy in preventing disease progression. However, treatment with cilostazol increased blood concentrations of albumin and β-amyloid complex, suggesting a potential role in clearing β-amyloid from the brain.

SourceNational Cerebral and Cardiovascular Center·JournalJAMA Network Open·DateDec 4, 2023

Newly identified cardiac progenitor cells shed light on diversity in complexity of heart formation

Researchers have identified specific progenitor cells in mouse embryos that differentiate into left ventricle cardiomyocytes, highlighting the complexity of early heart formation. The discovery provides insights into congenital heart disease mechanisms and may lead to improved treatments for left ventricle-related issues.

SourceNational Cerebral and Cardiovascular Center·JournalProceedings of the National Academy of Sciences·DateSep 5, 2023

Researchers identify the origin of endothelial cells that constitute the vascular niche for hematopoietic stem and progenitor cells in zebrafish

A team of researchers found that endoderm-derived endothelial cells contribute to zebrafish's functional vascular niche for hematopoietic stem and progenitor cells. The study proposes a new concept that endothelial specialization in the HSPC niche is determined, at least partially, by the origin of the ECs.

SourceNational Cerebral and Cardiovascular Center·JournalDevelopmental Cell·DateJan 23, 2023

Researchers identify a critical inhibitory site in an energy-producing enzyme, which can lead to rational design of antibiotics

A team of researchers has discovered a new mechanism to inhibit the critical enzyme in the respiratory chain, making it effective against drug-resistant strains of Neisseria gonorrhoeae. The findings could lead to the development of novel antibiotics with a different mechanism of action.

SourceNational Cerebral and Cardiovascular Center·JournalNature Communications·DateDec 8, 2022